Skip to main content
. 2021 Aug 27;17(6):508–515. doi: 10.4244/EIJ-D-20-01046

Table 3. Screening and presence of fibromuscular dysplasia.

n=373
No screening performed 33 (8.8)
Incomplete screening (at least one location screened) 63 (16.9)
Complete screening 277 (74.3)
Screening modality n=340
Computed tomographic angiography only 237 (69.7)
Magnetic resonance angiography only 37 (10.9)
Angiography during catheterisation only 7 (2.1)
Ultrasound only 3 (0.8)
Multimodal 56 (16.5)
Presence of FMD n=340
FMD 153 (45)
One localisation 95 (27.9)
Multifocal FMD 58 (17.1)
FMD prevalence and complete screening n=277
FMD 131 (47.3)
FMD localisation Carotid 63/288 (21.9)
Vertebral 20/289 (6.9)
Renal 93/330 (28.2)
Iliac 47/325 (14.5)
Visceral 16/263 (6.1)
Data are shown as n (%). FMD: fibromuscular dysplasia